Showing results (591-600 of 3,392) with videos related to

Sort By:
Pageof 340
Eclinicalmedicine|September 4, 2023
Statin use and risk of colorectal cancer in patients with inflammatory bowel diseaseJiangwei Sun, Jonas Halfvarson, David Bergman, et al.
Eclinicalmedicine|September 8, 2023
Oral streptococcal infective endocarditis among individuals at high risk following dental treatment: a nested case-crossover and case-control studyNiko Vähäsarja, Bodil Lund, Anders Ternhag, et al.
Eclinicalmedicine|September 8, 2023
Artificial intelligence aided precise detection of local recurrence on MRI for nasopharyngeal carcinoma: a multicenter cohort studyPu-Yun OuYang, Yun He, Jian-Gui Guo, et al.
Eclinicalmedicine|September 8, 2023
RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trialQihan Fu, Yi Zheng, Weijia Fang, et al.
Eclinicalmedicine|September 8, 2023
Parental substance use disorder and risk of intellectual disability in offspring in Sweden: a national register studyLotfi Khemiri, Ralf Kuja-Halkola, Henrik Larsson, et al.
Eclinicalmedicine|September 8, 2023
Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysisAnand V Kulkarni, Harshvardhan Tevethia, Karan Kumar, et al.
Eclinicalmedicine|August 18, 2023
Types, reporting and acceptability of community-based interventions for stillbirth prevention in sub-Saharan Africa (SSA): a systematic reviewUchenna Gwacham-Anisiobi, Yebeen Ysabelle Boo, Adetola Oladimeji, et al.
Eclinicalmedicine|August 21, 2023
The efficacy of physical exercise interventions on mental health, cognitive function, and ADHD symptoms in children and adolescents with ADHD: an umbrella reviewSima Dastamooz, Dena Sadeghi-Bahmani, Mohammad H D Farahani, et al.
Eclinicalmedicine|August 9, 2023
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerationsAndrea D'Arienzo, Annarita Verrazzo, Martina Pagliuca, et al.
Eclinicalmedicine|January 11, 2024
Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021)Daneng Li, Yohann Loriot, Adam M Burgoyne, et al.
Pageof 340